Evidence map›Paper›PMID 40901492›Full record

ArticleBiophysics and physicobiology2025

HulaChrimson: A Chrimson-like cation channelrhodopsin discovered using freshwater metatranscriptomics from Lake Hula.

Hiroto Takahashi, Shunki Takaramoto, Takashi Nagata, Shai Fainsod, Yoshitaka Kato, Oded Béjà, Keiichi Inoue

Abstract read
In one paragraph

Article in Biophysics and physicobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hiroto TakahashiThe Institute for Solid State Physics, The University of Tokyo, Kashiwa, Chiba 277-8581, Japan.
Shunki TakaramotoThe Institute for Solid State Physics, The University of Tokyo, Kashiwa, Chiba 277-8581, Japan.
Takashi NagataThe Institute for Solid State Physics, The University of Tokyo, Kashiwa, Chiba 277-8581, Japan.
Shai FainsodFaculty of Biology, Technion-Israel Institute of Technology, Haifa 3200003, Israel.
Yoshitaka KatoThe Institute for Solid State Physics, The University of Tokyo, Kashiwa, Chiba 277-8581, Japan.
Oded BéjàFaculty of Biology, Technion-Israel Institute of Technology, Haifa 3200003, Israel.
Keiichi InoueThe Institute for Solid State Physics, The University of Tokyo, Kashiwa, Chiba 277-8581, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chrimson is cation-conducting channelrhodopsin (CCR) with the most red-shifted absorption spectrum, rendering itself as one of the most promising optogenetic tools. However, the molecular mechanisms underlying its red-shifted absorption have not been completely clarified yet. Here, we found a CCR gene showing high sequence similarity to Chrimson from Lake Hula through freshwater metatranscriptome sampling. Interestingly, despite its high similarity to Chrimson, this CCR-named HulaChrimson-showed significantly blue-shifted action and absorption spectra compared to those of Chrimson. Mutations of amino acid residues, which are prominently different from those in Chrimson, in HulaChrimson did not reproduce the red-shifted absorption of Chrimson, suggesting the color-tuning between these proteins achieved by organizing the entire protein architecture, particularly in the broad hydrogen bonding network around the retinal Schiff base counterion, rather than by the difference in several specific residues. The optical characteristics of HulaChrimson distinct from those of Chrimson provide a basis for understanding the color-tuning mechanisms of channelrhodopsins.

Indexed as

Channelrhodopsincolor tuningpatch clampretinal

Identifiers

PMID40901492
PMCPMC12399511

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.